Insider · CIK 0001701858
Khalid Islam
Files at FENC (FENNEC PHARMACEUTICALS INC.), GANX (Gain Therapeutics, Inc.). First filing -, latest -.
Khalid Islam files SEC Form 4 as director at FENC (FENNEC PHARMACEUTICALS INC.), and also at GANX (Gain Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Khalid Islam has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionderivative | +25,000 | $8.70 | $218k | 250,000 | Jun 10, 2026 |
| Jun 24, 2025 | GANX Gain Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Jun 3, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionderivative | +25,000 | $7.88 | $197k | 225,000 | Jun 4, 2025 |
Questions about Khalid Islam
Answered from the filings on this page, as of the latest one.
Is Khalid Islam buying or selling?
Khalid Islam has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Khalid Islam's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Khalid Islam has 0.
Where does Khalid Islam file Form 4?
Khalid Islam has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.); GANX (Gain Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.